111 related articles for article (PubMed ID: 11910333)
1. Nursing perspectives on patient management during chronic therapy for relapsed ovarian cancer.
Frazier SR
Cancer Control; 2001; 8(6 Suppl 1):19-21. PubMed ID: 11910333
[No Abstract] [Full Text] [Related]
2. Ovarian cancer as a chronic disease: a new treatment paradigm. Highlights of a roundtable discussion.
Spriggs DR
Cancer Control; 2001; 8(6 Suppl 1):5-7; discussion 8-18. PubMed ID: 11910332
[No Abstract] [Full Text] [Related]
3. An overview of the management of recurrent breast cancer.
Burnet K
Int J Palliat Nurs; 2000; 6(7):318-9, 322-30. PubMed ID: 11309903
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for newly diagnosed and relapsed advanced ovarian cancer.
Rose PG
Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 2):25-35. PubMed ID: 14702918
[TBL] [Abstract][Full Text] [Related]
5. The value of serum and tissular expression of CA 125 antigen, in evaluation of the response to second line chemotherapy for the relapsed ovarian carcinoma.
Bădulescu F; Bădulescu A; Schenker M; Popescu CF; Stoica Z
Rom J Morphol Embryol; 2005; 46(4):329-34. PubMed ID: 16688372
[TBL] [Abstract][Full Text] [Related]
6. Advances in the Management of Platinum-Sensitive Relapsed Ovarian Cancer.
Bouberhan S; Pujade-Lauraine E; Cannistra SA
J Clin Oncol; 2019 Sep; 37(27):2424-2436. PubMed ID: 31403861
[No Abstract] [Full Text] [Related]
7. Prevention and treatment of adverse effects related to chemotherapy for recurrent ovarian cancer.
Edwards SJ
Semin Oncol Nurs; 2003 Aug; 19(3 Suppl 1):19-39. PubMed ID: 12971248
[TBL] [Abstract][Full Text] [Related]
8. Tumour markers in ovarian cancer.
Kehoe S; Selman T
Hosp Med; 2001 Aug; 62(8):452-3. PubMed ID: 11530581
[No Abstract] [Full Text] [Related]
9. Recurrent ovarian cancer.
Tummala MK; McGuire WP
Clin Adv Hematol Oncol; 2005 Sep; 3(9):723-36. PubMed ID: 16224447
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial management of patients with recurrent ovarian cancer: treating the whole patient to improve quality of life.
Fitch MI
Semin Oncol Nurs; 2003 Aug; 19(3 Suppl 1):40-53. PubMed ID: 12971249
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of CA-125 antigen for monitoring neoplastic processes in patients with ovarian tumors].
Kwaśniewska-Rokicińska C; Bartnikowa W; Koterbicka A; Deja R
Ginekol Pol; 1994 Mar; 65(3):136-41. PubMed ID: 8001848
[No Abstract] [Full Text] [Related]
12. [The value of CA 125 levels in serum, peritoneal fluid and tumor in women with ovarian cancer].
Markowska J; Wilkoszarska J
Ginekol Pol; 1996 Jul; 67(7):352-6. PubMed ID: 9138997
[TBL] [Abstract][Full Text] [Related]
13. [Caelyx once again recommended in recurrent ovarian carcinoma].
Krankenpfl J; 2005; 43(7-10):232. PubMed ID: 16518888
[No Abstract] [Full Text] [Related]
14. The role of ultrasound and tumour markers in the early detection of ovarian cancer.
Oram DH; Jeyarajah AR
Br J Obstet Gynaecol; 1994 Nov; 101(11):939-45. PubMed ID: 7999723
[No Abstract] [Full Text] [Related]
15. Subcutaneous infusion in palliative care: the neria soft infusion set.
Gabriel J
Br J Nurs; 2012 Nov 22-Dec 12; 21(21):S14, S16-8. PubMed ID: 23469516
[TBL] [Abstract][Full Text] [Related]
16. Lights and shadows of the tumoral marker CA-125 in ovarian cancer.
Sánchez Muñoz A; González Martín A; Mendiola Fernández C
Clin Transl Oncol; 2008 Aug; 10(8):449-52. PubMed ID: 18667373
[No Abstract] [Full Text] [Related]
17. Recent EORTC and MRC UK studies: implications for imaging ovarian cancer.
Spencer JA; Perren TJ
Cancer Imaging; 2010 Jul; 10(1):135-6. PubMed ID: 20605760
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer early detection program.
Farley KM
Oncol Nurs Forum; 1999 Jun; 26(5):833-4. PubMed ID: 10382179
[No Abstract] [Full Text] [Related]
19. One step at a time: self-management and transitions among women with ovarian cancer.
Schulman-Green D; Bradley EH; Nicholson NR; George E; Indeck A; McCorkle R
Oncol Nurs Forum; 2012 Jul; 39(4):354-60. PubMed ID: 22750893
[TBL] [Abstract][Full Text] [Related]
20. [Role of second-look surgery in treatment of ovarian neoplasms].
Markowska J; Szewierski Z; Roszak A; Niecewicz R
Ginekol Pol; 1996 Apr; 67(4):200-4. PubMed ID: 8846933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
